Delivery Order SPE2DB20D3101-SPE2DB25FRUH6
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,025.66 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Dexcom G7 sensors. This firm fixed-price delivery order, with completion scheduled for September 3, 2025, represents a non-competitive set-aside contract fulfilling federal medical procurement requirements. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,160.10 by the Defense Logistics Agency on August 12, 2025, for the supply of Dexcom G7 sensors. The contract represents a firm fixed price, non-set-aside award with an ultimate completion date of August 13, 2025, and will be fulfilled at the vendor's Conshohocken facility. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,822.66 for Dexcom G7 sensors by the Defense Logistics Agency (DLA). The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed price contract with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.80 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 15, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,749.25 to supply Dexcom G7 sensors, with an ultimate completion date of July 29, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $2,062.40 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with performance completed by August 5, 2025. This firm fixed price contract was awarded on August 4, 2025, without set-aside designation and represents a competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dexcom G7 continuous glucose monitoring sensors, valued at $3,093.60. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.999...
- The Defense Logistics Agency awarded a delivery order valued at $1,106.94 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract is a firm fixed price delivery order with no set-aside designation, issued on August 18, 2025, with an ultimate completion date of August 19, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,871.27 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed-price, competitively awarded contract was finalized on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUH6Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $2,892.38 for the supply of Dexcom G7 sensors. The contract, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, carries a firm fixed price structure and represents a competitively awarded, non-set-aside transaction. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The Defense Logistics Agency, operating under the Department of Defense, procures and distributes medical supplies to support military healthcare systems worldwide. As a critical pharmaceutical distributor, AmerisourceBergen maintains a significant role in the federal medical supply chain, delivering specialty pharmaceuticals and medical devices to support Defense Health Agency operations and other government healthcare systems. The Dexcom G7 sensors supplied under this order represent continuous glucose monitoring technology used for diabetes management within military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/3/25 |